Insurance Denied Allergy Testing or Immunotherapy? Appeal Guide

Allergic diseases — including allergic rhinitis, asthma, food allergies, and atopic dermatitis — affect more than 50 million Americans. Accurate diagnosis through allergy skin testing or specific IgE blood testing is the foundation for effective treatment, including allergen immunotherapy, which is the only disease-modifying treatment for IgE-mediated allergic disease. Yet insurers regularly deny both the testing and the treatment, often on grounds that are clinically inaccurate or legally questionable under the published guidelines of the major allergy and immunology professional societies.

Why Insurers Deny Allergy Testing and Immunotherapy

• Not medically necessary: Insurers argue that empiric antihistamine treatment should be tried before allergy testing, or that testing is premature for the patient's symptom duration or severity — ignoring AAAAI/ACAAI guidelines recommending testing to guide treatment selection
• Frequency limits on testing: Plans may limit allergy testing to once per year, denying repeat testing when a patient's allergy profile changes or a new allergen is suspected
• Immunotherapy Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization denied: Allergen immunotherapy (allergy shots, CPT 95115–95117) frequently requires prior authorization; if testing results are not submitted with the request or auth was not obtained, the claim is denied
• "Experimental" designation for sublingual immunotherapy (SLIT): While SLIT drops remain off-label in the US for most allergens, FDA-approved SLIT tablets (Grastek, Odactra, Ragwitek, Palforzia) are distinct from SLIT drops and must not be denied as experimental
• Out-of-network allergist: Allergy specialists may be out of network, triggering coverage disputes that may constitute network adequacy violations if no in-network specialist is available

Common denial codes: CO-50 (not medically necessary), CO-96 (non-covered service), CO-197 (prior authorization required), CO-119 (benefit maximum reached).

How to Appeal an Allergy Testing or Immunotherapy Denial

Step 1: Identify the Specific Denial Reason

Medical necessity disputes, prior authorization issues, frequency limit denials, and experimental service designations each require different responses. A frequency limit denial is resolved differently from a medical necessity challenge. Read the denial code and criteria carefully before drafting your appeal.

Step 2: Document Your Symptom History and Prior Treatment

For medical necessity appeals, gather records showing: duration and severity of allergic symptoms (rhinitis, asthma, skin reactions, food reactions); previous medications tried (antihistamines, nasal steroids, inhalers) and their documented outcomes; and how allergy symptoms affect daily functioning, work, school, or quality of life. The Joint Task Force on Practice Parameters — representing AAAAI and ACAAI — positions allergy skin testing as the most sensitive and specific method for identifying IgE-mediated sensitization and the standard of care for evaluating allergic rhinitis, asthma, and food allergy.

Step 3: Obtain a Clinical Necessity Letter from Your Allergist

The letter should: state the clinical indication for testing with ICD-10 codes (J30.1–J30.9 for allergic rhinitis, J45.x for asthma, L20.x for atopic dermatitis, Z91.01x for food allergy history); explain why allergy testing is necessary to guide treatment selection rather than continue empiric medication; cite AAAAI/ACAAI practice parameters; and for immunotherapy, document testing results, specific allergens identified, and why immunotherapy is indicated over continued pharmacotherapy.

Step 4: Challenge Experimental Designations for FDA-Approved SLIT Tablets

If your insurer denied FDA-approved SLIT tablets (Grastek for timothy grass, Odactra for house dust mite, Ragwitek for short ragweed, Palforzia for peanut allergy) as experimental, cite the FDA approval letters and phase III trial evidence published in the New England Journal of Medicine and Annals of Allergy journals. These products have full FDA approval and are not experimental. SLIT drops are a different matter and remain off-label — make sure you are appealing the correct product.

Step 5: Address Network Adequacy for Out-of-Network Allergist Denials

If your primary care physician referred you to an out-of-network allergist because no in-network specialist was available with timely appointments, document this as a network adequacy issue. Your insurer must ensure adequate access to in-network specialists. If they cannot provide one, they may be required to authorize out-of-network at in-network cost-sharing rates.

Step 6: Request Peer-to-Peer Review and External Independent Review

Request a peer-to-peer call between your allergist and the insurer's medical reviewer — allergists are highly effective in these calls because the clinical case for testing and immunotherapy is strong. If denied, request external review from a reviewer with allergy and immunology expertise.

What to Include in Your Appeal

• Physician notes documenting symptom history, severity, and prior treatment failures: With specific allergy-related ICD-10 diagnosis codes
• AAAAI/ACAAI practice parameters citation: Available at aaaai.org, establishing the clinical standard of care
• For SLIT tablets: FDA approval letter and drug label: Confirming the product has full regulatory approval
• Prior authorization request and denial correspondence: Documenting the insurer's procedural basis for denial
• For food allergy: NIAID 2017 guideline reference: Supporting specific IgE testing and oral food challenges as diagnostic standards

Fight Back With ClaimBack

Allergy testing and immunotherapy denials often rest on outdated criteria or a misapplication of the published evidence. When you present your clinical history alongside current AAAAI/ACAAI guidelines, these appeals succeed at high rates. ClaimBack generates a professional appeal letter in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal